Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Pivotal Trial of the FARAPULSE Pulsed Field Ablation System Compared With Standard of Care Ablation in Patients With Paroxysmal Atrial Fibrillation

NCT04612244 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT04612244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04612244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Pivotal Trial of the FARAPULSE Pulsed Field Ablation System Compared With Standard of Care Ablation in Patients With Paroxysmal Atrial Fibrillation
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2021
Completion date
May 15, 2023
Enrollment
706 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation